- Play for free
- Guide
-
Quick Nav
- Learn to Play
- Contractors
- Create Contractor
- Graveyard
- Gifts
- Create Gift
- Stock Gifts
- Community
-
Discord Server
- Looking for Game
- Find a Playgroup
- Hall of Fame
- Website
-
Get Early Access
- Buy Merchandise
- News and Updates
M.E.R.C.'s Journal
The Hand That Leads You
Downtime
Post mission 1 entry
I had hoped to vacate in Jamaica after the mission's completion, but instead I ended up in Haiti. I had hoped to return the rowboat to the newlywed couple, instead, I was hundreds of miles away. The mission could have been, should have been, a zero casualty mission.
Nothing went as planned.
Technically, a success, and I walked away unharmed. So by military standards, it was a "good" mission. Shared contact information on that long boat ride, still not sure about two of them. Frances feels like a civilian in a combat zone. Sam feels like a soldier, a skilled soldier no less, but overzealous, like Hodge. Momo, though, good head, prepared, versatile, and experienced in these contracts. I think she could be a useful ally.
Now I just got to get back home, thank god I still have $750. With Haiti's economy and my military background, the consulate should be able to easily get me back stateside.
Gen-Wyld: Beyond Natural
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.